| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Center for Health Studies (Dr. Von Korff), Group Health Cooperative of Puget Sound, Seattle, WA; the Department of Epidemiology (Drs. Stewart and Simon), Johns Hopkins School of Hygiene and Public Health, Baltimore, MD; the Department of Neurology, Epidemiology and Social Medicine (Dr. Lipton), Albert Einstein College of Medicine and The Headache Unit, Montefiore Medical Center, Bronx, Ny; and Innovative Medical Research (Drs. Stewart and Lipton), Towson, MD.
Address correspondence and reprint requests to Dr. Michael Von KoB, Center for Health Studies, Group Health Cooperative of Puget Sound, 1730 Minor Ave. Suite 1600, Seattle, WA 98101.
objectiue This article estimates lost work days and lost work day equivalents in a population sample of migraineurs, differentiating work loss due to headache episodes that met criteria for migraine from migrainous headaches not meeting full criteria and nonmigrainous headaches.
Methods A random digit dialing survey of 5,071 adults identified 800 subjects with migraine headaches. By clinical examination, a subsample of 225 met migraine diagnostic criteria; 174 of these patients completed at least 11 weeks of daily diaries. This report concerns the subgroup of 122 individuals with regular paid employment. Subjects completed a daily diary over a 3-month period to assess the occurrence of headaches and International Headache Society (IHS) criteria for each headache occurrence. We report estimates of lost work days and lost work day equivalents by type of headache.
Results Participants reported headaches on 8.1 work days, of which 2.2 headache days met criteria for migraine (IHS 1.1, 1.2), and an additional 2.1 headache days were migrainous without meeting full migraine criteria (IHS 1.7). On average, migraineurs missed 1.1 days of work due to headache in 3 months, of which 0.7 lost work days were due to migraine and 0.3 were due to migrainous headaches. When at work with headache, work effectiveness was reduced 41% for migraine headaches, 28% for migrainous headaches, and 24% for other headaches. Over 3 months, migraineurs experienced an average of 3.0 lost work day equivalents, of which 1.4 were due to migraine and an additional 0.7 were due to migrainous headaches. The most disabled 20% of the participants accounted for 77% of the lost work days; 40% of subjects accounted for 75% of the lost work day equivalents.
Conclusions Employed migraine sufferers experienced considerable work loss and reduced work performance due to headache. The most severely affected migraineurs accounted for most of the reduced work performance. Targeting the most severely affected persons may be necessary to reduce work loss among migraineurs substantially. NEUROLOGY 1998;50:1741–1745
Supported by Glaxo Wellcome Inc.
Received July 18, 1997. Accepted in final form February 26, 1998.
This article has been cited by other articles:
|
|
 |
|
  W. N. Burton, S. H. Landy, K. E. Downs, and M. C. Runken The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research Mayo Clin. Proc., May 1, 2009; 84(5): 436 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Siva, M. Zarifoglu, M. Ertas, S. Saip, H. N. Karli, B. Baykan, A. Keskinaslan, and M. Senocak Validity of the ID-Migraine screener in the workplace Neurology, April 15, 2008; 70(16): 1337 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Saunders, K. Merikangas, N.C.P. Low, M. V. Korff, and R. C. Kessler Impact of comorbidity on headache-related disability Neurology, February 12, 2008; 70(7): 538 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Haythornthwaite Clinical trials studying pharmacotherapy and psychological treatments alone and together Neurology, December 29, 2005; 65(12_suppl_4): S20 - S31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Lipton, M. E. Bigal, and W. F. Stewart Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life Neurology, December 29, 2005; 65(12_suppl_4): S50 - S58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Stewart, J. A. Ricci, E. Chee, D. Morganstein, and R. Lipton Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce JAMA, November 12, 2003; 290(18): 2443 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.B. Lipton, D. Dodick, R. Sadovsky, K. Kolodner, J. Endicott, J. Hettiarachchi, and W. Harrison A self-administered screener for migraine in primary care: The ID MigraineTM validation study Neurology, August 12, 2003; 61(3): 375 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Breslau, R. B. Lipton, W. F. Stewart, L. R. Schultz, and K. M.A. Welch Comorbidity of migraine and depression: Investigating potential etiology and prognosis Neurology, April 22, 2003; 60(8): 1308 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J Goadsby and C. Boes CHRONIC DAILY HEADACHE J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(90002): ii2 - 5. [Full Text]
|
|
|
|
 |
|
 S. I. Bekkelund and R. Salvesen Are headache patients who initiate their referral to a neurologist satisfied with the consultation? A population study of 927 patients--the North Norway Headache Study (NNHS) Fam. Pract., October 1, 2001; 18(5): 524 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Holmes, E. A. MacGregor, and D. Dodick Migraine-related disability: Impact and implications for sufferers' lives and clinical issues Neurology, March 1, 2001; 56(suppl_1): S13 - S19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Stewart, R. B. Lipton, A. J. Dowson, and J. Sawyer Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability Neurology, March 1, 2001; 56(suppl_1): S20 - S28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Edmeads, J. M. Lainez, J. L. Brandes, J. Schoenen, and F. Freitag Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice Neurology, March 1, 2001; 56(suppl_1): S29 - S34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Matchar, D. C. McCrory, and R. N. Gray Toward Evidence-Based Management of Migraine JAMA, November 22, 2000; 284(20): 2640 - 2641. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Silberstein and J. Rosenberg Multispecialty consensus on diagnosis and treatment of headache Neurology, April 25, 2000; 54(8): 1553 - 1553. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goadsby, M. D. Ferrari, J. Olesen, L. J. Stovner, J. M. Senard, N. C. Jackson, and P. H. Poole Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan Neurology, January 11, 2000; 54(1): 156 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Cady Reduction of Labor Costs Associated With Treating Migraine in the Workplace Arch Intern Med, January 25, 1999; 159(2): 197 - 197. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
